SG10201907877YA - Modulation of macrophage activation - Google Patents
Modulation of macrophage activationInfo
- Publication number
- SG10201907877YA SG10201907877YA SG10201907877YA SG10201907877YA SG10201907877YA SG 10201907877Y A SG10201907877Y A SG 10201907877YA SG 10201907877Y A SG10201907877Y A SG 10201907877YA SG 10201907877Y A SG10201907877Y A SG 10201907877YA SG 10201907877Y A SG10201907877Y A SG 10201907877YA
- Authority
- SG
- Singapore
- Prior art keywords
- macrophage activation
- cells
- modulate
- modulation
- directed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
MODULATION OF MACROPHAGE ACTIVATION The invention provides methods for treating pathological conditions associated with an undesirable inflammatory component. The invention is generally directed to reducing inflammation by administering cells that modulate macrophage activation. The invention is also directed to drug discovery methods to screen for agents that modulate the ability of the cells to modulate macrophage activation. The invention is also directed to cell banks that can be used to provide cells for administration to a subject, the banks comprising cells having desired potency to modulate macrophage activation. [No Suitable Figure] 46
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30808210P | 2010-02-25 | 2010-02-25 | |
US31664710P | 2010-03-23 | 2010-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201907877YA true SG10201907877YA (en) | 2019-09-27 |
Family
ID=44507208
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2012063186A SG183497A1 (en) | 2010-02-25 | 2011-02-24 | Modulation of macrophage activation |
SG10201501402UA SG10201501402UA (en) | 2010-02-25 | 2011-02-24 | Modulation of macrophage activation |
SG10201907877YA SG10201907877YA (en) | 2010-02-25 | 2011-02-24 | Modulation of macrophage activation |
SG10201914001QA SG10201914001QA (en) | 2010-02-25 | 2011-02-24 | Modulation of macrophage activation |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2012063186A SG183497A1 (en) | 2010-02-25 | 2011-02-24 | Modulation of macrophage activation |
SG10201501402UA SG10201501402UA (en) | 2010-02-25 | 2011-02-24 | Modulation of macrophage activation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201914001QA SG10201914001QA (en) | 2010-02-25 | 2011-02-24 | Modulation of macrophage activation |
Country Status (7)
Country | Link |
---|---|
US (1) | US20110305638A1 (en) |
EP (2) | EP3940060A1 (en) |
AU (1) | AU2011220721B2 (en) |
DK (1) | DK2539436T3 (en) |
IL (2) | IL282662B2 (en) |
SG (4) | SG183497A1 (en) |
WO (1) | WO2011106521A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2009205886B2 (en) | 2008-01-18 | 2015-08-27 | Katholieke Universiteit Leuven | Stem cell aggregates and methods for making and using |
SG193847A1 (en) * | 2008-09-04 | 2013-10-30 | Abt Holding Co | Use of stem cells to prevent neuronal dieback |
EP2568991B3 (en) | 2010-05-12 | 2018-11-28 | ABT Holding Company | Modulation of splenocytes in cell therapy |
EP2639313A1 (en) * | 2012-03-14 | 2013-09-18 | Rheinische Friedrich-Wilhelms-Universität Bonn | High-resolution transcriptome of human macrophages |
CN105338989B (en) | 2013-04-12 | 2022-04-08 | 赛维里奥·拉弗朗切西卡 | Improvements in organs for transplantation |
MX2018001182A (en) * | 2015-07-28 | 2018-04-20 | Univ Pennsylvania | Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof. |
NZ745530A (en) | 2016-01-21 | 2023-03-31 | Abt Holding Co | Stem cells for wound healing |
CN106929474B (en) * | 2017-03-31 | 2021-09-14 | 北京恒峰铭成生物科技有限公司 | M2 macrophage inducer |
WO2021217098A1 (en) * | 2020-04-23 | 2021-10-28 | Abt Holding Company | Treatment of virus-induced acute respiratory distress syndrome |
CA3184807A1 (en) | 2020-06-04 | 2021-12-09 | Carisma Therapeutics Inc. | Novel constructs for chimeric antigen receptors |
Family Cites Families (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4353888A (en) | 1980-12-23 | 1982-10-12 | Sefton Michael V | Encapsulation of live animal cells |
US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
US4744933A (en) | 1984-02-15 | 1988-05-17 | Massachusetts Institute Of Technology | Process for encapsulation and encapsulated active material system |
US4749620A (en) | 1984-02-15 | 1988-06-07 | Massachusetts Institute Of Technology | Encapsulated active material system |
JPH0628570B2 (en) | 1986-02-13 | 1994-04-20 | 雪印乳業株式会社 | Method and device for manufacturing capsule body |
EP0301777A1 (en) | 1987-07-28 | 1989-02-01 | Queen's University At Kingston | Multiple membrane microencapsulation |
US5192553A (en) | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
NZ230723A (en) | 1988-09-21 | 1992-07-28 | Cambridge Animal Biotech | Pluripotential embryonic stem cells isolated from an embryonic disc, methods of producing transgenic cells and a chimeric foetus |
US5089272A (en) | 1989-03-29 | 1992-02-18 | Snow Brand Milk Products Co., Ltd. | Process for producing capsules having a permeability-controllable membrane |
US7037721B1 (en) | 1990-01-29 | 2006-05-02 | Hy-Gene Biomedical, Inc. | Protein-free defined media for the growth of normal human keratinocytes |
US5084350A (en) | 1990-02-16 | 1992-01-28 | The Royal Institution For The Advance Of Learning (Mcgill University) | Method for encapsulating biologically active material including cells |
US5061620A (en) | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5635387A (en) | 1990-04-23 | 1997-06-03 | Cellpro, Inc. | Methods and device for culturing human hematopoietic cells and their precursors |
US5811094A (en) | 1990-11-16 | 1998-09-22 | Osiris Therapeutics, Inc. | Connective tissue regeneration using human mesenchymal stem cell preparations |
US5837539A (en) | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
GB2254289B (en) | 1991-04-05 | 1995-03-22 | Gerber Garment Technology Inc | Readily transferrable adherent tape and methods of use and making |
US5851832A (en) | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
CA2123094C (en) | 1991-11-06 | 1999-08-10 | Paulo N. Correa | Cell culture medium |
US5578442A (en) | 1992-03-23 | 1996-11-26 | Vivorx, Inc. | Graft copolymers of polycationic species and water-soluble polymers, and use therefor |
US5460964A (en) | 1992-04-03 | 1995-10-24 | Regents Of The University Of Minnesota | Method for culturing hematopoietic cells |
US5340740A (en) | 1992-05-15 | 1994-08-23 | North Carolina State University | Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process |
WO1994000484A1 (en) | 1992-06-22 | 1994-01-06 | Young Henry E | Scar inhibitory factor and use thereof |
US5849553A (en) | 1992-07-27 | 1998-12-15 | California Institute Of Technology | Mammalian multipotent neural stem cells |
US5564183A (en) | 1992-09-30 | 1996-10-15 | Matsushita Electric Industrial Co., Ltd. | Producing system of printed circuit board and method therefor |
US5453357A (en) | 1992-10-08 | 1995-09-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
US7153684B1 (en) | 1992-10-08 | 2006-12-26 | Vanderbilt University | Pluripotential embryonic stem cells and methods of making same |
US5766951A (en) | 1992-11-12 | 1998-06-16 | Quality Biological, Inc. | Serum-free medium supporting growth and proliferation of normal bone marrow cells |
US5766948A (en) | 1993-01-06 | 1998-06-16 | The Regents Of The University Of California | Method for production of neuroblasts |
EP1179350A3 (en) | 1993-08-12 | 2003-01-02 | Cytotherapeutics, Inc. | Encapsulated cell system for implantation into the human CNS |
US6037174A (en) | 1993-08-23 | 2000-03-14 | Nexell Therapeutics, Inc. | Preparation of serum-free suspensions of human hematopoietic cells or precursor cells |
US5409813A (en) | 1993-09-30 | 1995-04-25 | Systemix, Inc. | Method for mammalian cell separation from a mixture of cell populations |
US6432711B1 (en) | 1993-11-03 | 2002-08-13 | Diacrin, Inc. | Embryonic stem cells capable of differentiating into desired cell lines |
FR2726003B1 (en) | 1994-10-21 | 2002-10-18 | Agronomique Inst Nat Rech | CULTURE MEDIUM OF AVIAN TOTIPOTENT EMBRYONIC CELLS, METHOD FOR CULTURING THESE CELLS, AND AVIAN TOTIPOTENT EMBRYONIC CELLS |
US5677136A (en) | 1994-11-14 | 1997-10-14 | Systemix, Inc. | Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof |
US5914268A (en) | 1994-11-21 | 1999-06-22 | National Jewish Center For Immunology & Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5874301A (en) | 1994-11-21 | 1999-02-23 | National Jewish Center For Immunology And Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
US5736396A (en) | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
US5837670A (en) | 1995-04-18 | 1998-11-17 | Hartshorn; Richard Timothy | Detergent compositions having suds suppressing properties |
US5908782A (en) | 1995-06-05 | 1999-06-01 | Osiris Therapeutics, Inc. | Chemically defined medium for human mesenchymal stem cells |
US6015554A (en) | 1995-06-07 | 2000-01-18 | Systemix, Inc. | Method of reconstituting human lymphoid and dendritic cells |
US6190910B1 (en) | 1996-05-21 | 2001-02-20 | The Institute Of Physical And Chemical Research | Mouse embryonic stem cell lines |
US5753506A (en) | 1996-05-23 | 1998-05-19 | Cns Stem Cell Technology, Inc. | Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals |
US5827740A (en) | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
US5945337A (en) | 1996-10-18 | 1999-08-31 | Quality Biological, Inc. | Method for culturing CD34+ cells in a serum-free medium |
US6361996B1 (en) | 1997-05-07 | 2002-03-26 | University Of Utah Research Foundation | Neuroepithelial stem cells and glial-restricted intermediate precursors |
AU7984498A (en) | 1997-06-25 | 1999-01-04 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Serum-free cell growth medium |
CA2294737A1 (en) | 1997-07-04 | 1999-01-14 | University Of Utah Research Foundation | Neuron-restricted precursor cells |
US5968829A (en) | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
RU2272839C2 (en) | 1998-11-09 | 2006-03-27 | Консорцио Пер Ла Джестионе Дель Чентро Ди Биотекнолоджие Аванцате | Serum-free medium for cultured cells used for reconstruction of osseous and cartilage segments (variants) |
EP1129176A4 (en) | 1998-11-09 | 2002-10-30 | Es Cell Int Pte Ltd | Embryonic stem cells |
US20050153442A1 (en) | 1999-03-10 | 2005-07-14 | Adam Katz | Adipose-derived stem cells and lattices |
US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
US8075881B2 (en) * | 1999-08-05 | 2011-12-13 | Regents Of The University Of Minnesota | Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure |
WO2001098463A1 (en) | 2000-06-20 | 2001-12-27 | Es Cell International Pte Ltd | Method of controlling differentiation of embryonic stem (es) cells by culturing es cells in the presence of bmp-2 pathway antagonists |
US7560280B2 (en) | 2000-11-03 | 2009-07-14 | Kourion Therapeutics Gmbh | Human cord blood derived unrestricted somatic stem cells (USSC) |
JP2004529621A (en) | 2001-02-14 | 2004-09-30 | ティー ファークト,レオ | Pluripotent adult stem cells, their origin, methods of obtaining and maintaining them, methods of differentiating them, methods of their use, and cells derived therefrom |
BR0212098A (en) | 2001-08-23 | 2004-08-03 | Reliance Life Sciences Pvt Ltd | Internal cell mass isolation method for the establishment of human embryonic stem cell lines (hesc) |
US9969980B2 (en) | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
US6703279B2 (en) | 2002-01-04 | 2004-03-09 | Promos Technologies, Inc. | Semiconductor device having contact of Si-Ge combined with cobalt silicide |
JP2005515777A (en) | 2002-01-25 | 2005-06-02 | ジェンザイム・コーポレーション | Serum-free medium for chondrocytes and use thereof |
US7145057B2 (en) | 2002-02-01 | 2006-12-05 | Origen Therapeutics, Inc. | Chimeric bird from embryonic stem cells |
AU2003230695A1 (en) | 2002-03-20 | 2003-10-08 | Sara Griffin | Sports training device |
GB0221481D0 (en) | 2002-09-16 | 2002-10-23 | Richards John M | Grip for hand held instruments |
US20060210544A1 (en) * | 2003-06-27 | 2006-09-21 | Renomedix Institute, Inc. | Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient |
EP2298862B1 (en) * | 2004-03-22 | 2017-08-30 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
US7670596B2 (en) * | 2004-04-23 | 2010-03-02 | Bioe, Inc. | Multi-lineage progenitor cells |
CA2642826C (en) * | 2006-01-23 | 2019-01-08 | Athersys, Inc. | Mapc treatment of brain injuries and diseases |
WO2008057469A1 (en) * | 2006-11-02 | 2008-05-15 | Wyeth | Small organic molecule regulators of cell proliferation |
EP2279246A4 (en) * | 2008-05-02 | 2012-03-28 | Massachusetts Inst Technology | Methods and compositions for modulating immunological tolerance |
WO2009137836A2 (en) * | 2008-05-09 | 2009-11-12 | Hemogenix, Inc. | Cell potency assay |
SG193847A1 (en) * | 2008-09-04 | 2013-10-30 | Abt Holding Co | Use of stem cells to prevent neuronal dieback |
US20130129686A1 (en) * | 2009-11-19 | 2013-05-23 | Regents Of The University | Reducing Inflammation Using Cell Therapy |
US20160069903A1 (en) * | 2014-09-10 | 2016-03-10 | Fundació Institute De Ciències Foròniques | Method for detecting cells |
-
2011
- 2011-02-24 AU AU2011220721A patent/AU2011220721B2/en active Active
- 2011-02-24 IL IL282662A patent/IL282662B2/en unknown
- 2011-02-24 SG SG2012063186A patent/SG183497A1/en unknown
- 2011-02-24 SG SG10201501402UA patent/SG10201501402UA/en unknown
- 2011-02-24 EP EP21175415.5A patent/EP3940060A1/en active Pending
- 2011-02-24 SG SG10201907877YA patent/SG10201907877YA/en unknown
- 2011-02-24 EP EP11748062.4A patent/EP2539436B1/en active Active
- 2011-02-24 SG SG10201914001QA patent/SG10201914001QA/en unknown
- 2011-02-24 DK DK11748062.4T patent/DK2539436T3/en active
- 2011-02-24 WO PCT/US2011/026067 patent/WO2011106521A1/en active Application Filing
- 2011-03-25 US US13/071,801 patent/US20110305638A1/en not_active Abandoned
-
2019
- 2019-04-04 IL IL265832A patent/IL265832B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20110305638A1 (en) | 2011-12-15 |
SG10201501402UA (en) | 2015-04-29 |
SG10201914001QA (en) | 2020-03-30 |
DK2539436T3 (en) | 2021-10-18 |
IL282662A (en) | 2021-06-30 |
EP2539436B1 (en) | 2021-09-22 |
EP2539436A1 (en) | 2013-01-02 |
IL265832A (en) | 2019-06-30 |
EP2539436A4 (en) | 2013-08-14 |
AU2011220721B2 (en) | 2015-02-05 |
SG183497A1 (en) | 2012-09-27 |
IL265832B (en) | 2022-05-01 |
IL282662B1 (en) | 2023-09-01 |
AU2011220721A1 (en) | 2012-09-20 |
EP3940060A1 (en) | 2022-01-19 |
IL282662B2 (en) | 2024-01-01 |
WO2011106521A1 (en) | 2011-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201907877YA (en) | Modulation of macrophage activation | |
AU2010236286A8 (en) | Modulation of inflammatory responses by Factor XI | |
BRMU8901002Y8 (en) | constructive arrangement for a bandage bearing an electrical transcutaneous nerve stimulator device | |
SG10201809638YA (en) | Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same | |
EA201390879A1 (en) | TRICYCLIC INHIBITORS PI3K AND METHODS OF THEIR APPLICATION | |
MX345928B (en) | Therapeutically active compositions and their methods of use. | |
AU2012284088A8 (en) | Heterocyclic compounds and uses thereof | |
EA201591403A1 (en) | SPIROLACTAM NMDA RECEPTOR MODULATORS AND THEIR APPLICATION | |
EP2853543A8 (en) | Anti-blys antibody | |
MY175431A (en) | Composite tower for power grid transmission line and composite cross arm structure thereof | |
WO2013003731A3 (en) | Methods of treating recurrent meibomian glands disorder and thereby decreasing the frequency of recurrence | |
MY175979A (en) | Certain chemical entities, compositions and methods | |
MX2013005654A (en) | Compositions and methods for 3-hydroxypropionic acid production. | |
SG10201811584RA (en) | Secondary Structure Stabilized NMDA Receptor Modulators And Uses Thereof | |
MX2013010945A (en) | Systhesis of 5-azacytidine. | |
EP4327886A3 (en) | Pyrimido- pyridazinone compounds and use thereof | |
PH12015502745A1 (en) | 4-alkynyl imidazole derivative and medicine comprising same as active ingredient | |
TN2014000001A1 (en) | A new therapeutical composition containing apomorphine as active ingredient | |
MX361157B (en) | Dioxino- and oxazin-[2,3-d]pyrimidine pi3k inhibitor compounds and methods of use. | |
WO2012037043A8 (en) | Treatment of autoimmune inflammation using mir-155 | |
MX2015001488A (en) | Treating inflammation using serelaxin. | |
MX2014014814A (en) | Pharmaceutical composition for treating inflammation and pain. | |
AU2012307257A8 (en) | Pharmaceutical combinations including anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders | |
MX368640B (en) | PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION and PAIN. | |
WO2013121300A3 (en) | Methods for treating psoriasis and vascular inflammation |